- Home
- CRDO vs LNTH Comparison
CRDO vs LNTH Comparison
Compare CRDO & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDO
- LNTH
- Stock Information
- Founded
- CRDO 2008
- LNTH 1956
- Country
- CRDO Cayman Islands
- LNTH United States
- Employees
- CRDO N/A
- LNTH N/A
- Industry
- CRDO Semiconductors
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- CRDO Technology
- LNTH Health Care
- Exchange
- CRDO Nasdaq
- LNTH Nasdaq
- Market Cap
- CRDO 7.3B
- LNTH 7.5B
- IPO Year
- CRDO 2022
- LNTH 2015
- Fundamental
- Price
- CRDO $59.43
- LNTH $80.10
- Analyst Decision
- CRDO Strong Buy
- LNTH Strong Buy
- Analyst Count
- CRDO 10
- LNTH 5
- Target Price
- CRDO $68.00
- LNTH $133.80
- AVG Volume (30 Days)
- CRDO 3.5M
- LNTH 1.2M
- Earning Date
- CRDO 05-28-2025
- LNTH 05-07-2025
- Dividend Yield
- CRDO N/A
- LNTH N/A
- EPS Growth
- CRDO N/A
- LNTH N/A
- EPS
- CRDO 0.03
- LNTH 3.53
- Revenue
- CRDO $327,532,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- CRDO $125.51
- LNTH $5.81
- Revenue Next Year
- CRDO $58.55
- LNTH $12.26
- P/E Ratio
- CRDO $1,784.22
- LNTH $22.52
- Revenue Growth
- CRDO 99.38
- LNTH 12.53
- 52 Week Low
- CRDO $16.98
- LNTH $74.34
- 52 Week High
- CRDO $86.69
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- CRDO 71.37
- LNTH 29.71
- Support Level
- CRDO $45.65
- LNTH $78.61
- Resistance Level
- CRDO $49.44
- LNTH $83.60
- Average True Range (ATR)
- CRDO 2.44
- LNTH 3.81
- MACD
- CRDO 1.71
- LNTH -3.05
- Stochastic Oscillator
- CRDO 97.72
- LNTH 5.51
About CRDO Credo Technology Group Holding Ltd
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.